BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36625218)

  • 1. Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging.
    Khunte M; Chae A; Wang R; Jain R; Sun Y; Sollee JR; Jiao Z; Bai HX
    Clin Radiol; 2023 Feb; 78(2):123-129. PubMed ID: 36625218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA-regulated AI Algorithms: Trends, Strengths, and Gaps of Validation Studies.
    Ebrahimian S; Kalra MK; Agarwal S; Bizzo BC; Elkholy M; Wald C; Allen B; Dreyer KJ
    Acad Radiol; 2022 Apr; 29(4):559-566. PubMed ID: 34969610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks.
    Muehlematter UJ; Bluethgen C; Vokinger KN
    Lancet Digit Health; 2023 Sep; 5(9):e618-e626. PubMed ID: 37625896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
    Clark P; Kim J; Aphinyanaphongs Y
    JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
    Zhu S; Gilbert M; Chetty I; Siddiqui F
    Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value Proposition of FDA-Approved Artificial Intelligence Algorithms for Neuroimaging.
    Bajaj S; Khunte M; Moily NS; Payabvash S; Wintermark M; Gandhi D; Malhotra A
    J Am Coll Radiol; 2023 Dec; 20(12):1241-1249. PubMed ID: 37574094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.
    Potnis KC; Ross JS; Aneja S; Gross CP; Richman IB
    JAMA Intern Med; 2022 Dec; 182(12):1306-1312. PubMed ID: 36342705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database.
    Benjamens S; Dhunnoo P; Meskó B
    NPJ Digit Med; 2020; 3():118. PubMed ID: 32984550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA-approved machine learning algorithms in neuroradiology: A systematic review of the current evidence for approval.
    Yearley AG; Goedmakers CMW; Panahi A; Doucette J; Rana A; Ranganathan K; Smith TR
    Artif Intell Med; 2023 Sep; 143():102607. PubMed ID: 37673576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence and remote patient monitoring in US healthcare market: a literature review.
    Dubey A; Tiwari A
    J Mark Access Health Policy; 2023; 11(1):2205618. PubMed ID: 37151736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA Review of Radiologic AI Algorithms: Process and Challenges.
    Zhang K; Khosravi B; Vahdati S; Erickson BJ
    Radiology; 2024 Jan; 310(1):e230242. PubMed ID: 38165243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies.
    Zinchenko VV; Arzamasov KM; Chetverikov SF; Maltsev AV; Novik VP; Akhmad ES; Sharova DE; Andreychenko AE; Vladzymyrskyy AV; Morozov SP
    Sovrem Tekhnologii Med; 2022; 14(5):15-23. PubMed ID: 37181834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status and future of FDA-approved artificial intelligence tools in chest radiology in the United States.
    Milam ME; Koo CW
    Clin Radiol; 2023 Feb; 78(2):115-122. PubMed ID: 36180271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Clinical Applications of Artificial Intelligence in Radiology and Their Best Supporting Evidence.
    Tariq A; Purkayastha S; Padmanaban GP; Krupinski E; Trivedi H; Banerjee I; Gichoya JW
    J Am Coll Radiol; 2020 Nov; 17(11):1371-1381. PubMed ID: 33153541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature artificial intelligence- and machine learning-enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration-approved or cleared technologies relevant to vascular surgeons.
    Stonko DP; Hicks CW
    Semin Vasc Surg; 2023 Sep; 36(3):460-470. PubMed ID: 37863621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Need for Medical Artificial Intelligence That Incorporates Prior Images.
    Acosta JN; Falcone GJ; Rajpurkar P
    Radiology; 2022 Aug; 304(2):283-288. PubMed ID: 35438563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory environment for artificial intelligence-enabled devices in the United States.
    Liang NL; Chung TK; Vorp DA
    Semin Vasc Surg; 2023 Sep; 36(3):435-439. PubMed ID: 37863617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration.
    Ball R; Talal AH; Dang O; Muñoz M; Markatou M
    J Med Internet Res; 2024 Jun; 26():e50274. PubMed ID: 38842929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the FDA Regulates AI.
    Harvey HB; Gowda V
    Acad Radiol; 2020 Jan; 27(1):58-61. PubMed ID: 31818387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
    Muehlematter UJ; Daniore P; Vokinger KN
    Lancet Digit Health; 2021 Mar; 3(3):e195-e203. PubMed ID: 33478929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.